Optimal Balance Pharmacy recalls Glutathione 200 mg/mL vials due to bacterial endotoxin contamination. These sterile injections may cause infections if used improperly.
“Optimal Balance Pharmacy Glutathione Vials Contain Bacterial Endotoxins.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/1004740-optimal-balance-pharmacy-glutathione-vials-contain-bacterial-endotoxins. Based on FDA recall #D-0851-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0851-2026%22&limit=1).
The Food and Drug Administration announced on August 5, 2026, that Optimal Balance Pharmacy is voluntarily recalling Glutathione 200 mg/mL sterile multidose vials due to microbial contamination risks. The recall affects 53 units distributed nationwide.
How to tell if you have it
Brand: Optimal Balance Pharmacy
Product: Glutathione 200 mg/mL, 30 mL sterile multidose vial
Lot code: LG342009076
Beyond Use Date: 10/4/26
Quantity: 53 vials
The hazard
The recall is due to out-of-specification results for bacterial endotoxin in the sterile multidose vials. The product contains Glutathione, Ascorbic Acid, Benzyl Alcohol, and sterile water for injection.
Context
GovInfoNow's records show that Victory Medical Center Pharmacy issued a recall for Glutathione vials on July 1, 2026, citing bacterial contamination risk. Other recent recalls of similar products include New Life Pharma Tirzepatide 10mg Vial Recall (February 26, 2026) and Chiesi CLEVIPREX 50mg/100mL injectable vials (July 6, 2026).
How to tell if you have this one
Check for vials labeled 'Glutathione 200 mg/mL, 30 mL sterile multidose' from Optimal Balance Pharmacy. The lot number LG342009076 and expiration date 10/4/26 are specific identifiers.
Brand
Optimal Balance Pharmacy
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Vial Details
Look for the lot number LG342009076 and expiration date 10/4/26 on the vial label.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “USA Nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 35 days after the firm started it.
1Firm started the recall
2Published in FDA’s Enforcement Report
3FDA classified it Class I
4Added to GovInfoNow
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0851-2026 (August 5, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0851-2026 to see it in context.
Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.